• Have a deep scientific knowledge of Genmab’s products and pipeline, their target disease areas, and the competitive landscape. • Build and maintain a strategic engagement plan with key payor accounts in assigned geographies • Work in close coordination with National HEOLs to ensure alignment of strategy and tactics seamlessly flow from National to Regional accounts (ex. GPO >>> LPG). • Identify key accounts and RWE experts that align with CORE AOIs and appropriately liaise opportunities and ongoing CORE studies to internal leads. • Understand the access landscape including regional payer policies and pathways in respective therapeutic areas. • In close collaboration with the US Market Access team, execute engagement strategy for key payer customers (regional payers, health systems, large practice groups (LPGs)/community networks, and regional strategic partners) for compliant delivery of pre-approval information exchange (PIE), HCEI, RWE, and clinical materials. • Be fluent in HCEI and clinical content prepared by CORE for engagements with PHDMs at local/regional payor accounts. • Provide medical and HCEI leadership supporting the access and operationalization of Genmab therapies across health systems. • Provide clinical, humanistic, and HCEI education relative to target disease states and Genmab clinical trials to payers and PHDMs. • Present appropriate economic and clinical information to PHDMs in response to unsolicited requests (as appropriate) in a fair and balanced manner. • Develop and establish relationships with key PHDMs and bring forth appropriate collaboration opportunities that meet USMA and Genmab goals and objectives. • Provide insights/feedback to internal CORE and Medical Strategy team members on emerging economic/clinical and real-world data that enhance the value and appropriate use of Genmab products • Collaborate effectively and proactively establish working relationships with cross-functional teams including internal CORE, US Medical Affairs, Field Medical Affairs (FMA), and Market Access • Professionally represent Genmab at select medical and scientific conferences including providing scientific coverage and competitive intelligence